- Home
- WEAV vs IMCR Comparison
WEAV vs IMCR Comparison
Compare WEAV & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WEAV
- IMCR
- Stock Information
- Founded
- WEAV 2011
- IMCR 2008
- Country
- WEAV United States
- IMCR United Kingdom
- Employees
- WEAV N/A
- IMCR N/A
- Industry
- WEAV EDP Services
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WEAV Technology
- IMCR Health Care
- Exchange
- WEAV Nasdaq
- IMCR Nasdaq
- Market Cap
- WEAV 1.3B
- IMCR 1.5B
- IPO Year
- WEAV 2021
- IMCR 2021
- Fundamental
- Price
- WEAV $14.25
- IMCR $29.92
- Analyst Decision
- WEAV Strong Buy
- IMCR Buy
- Analyst Count
- WEAV 5
- IMCR 13
- Target Price
- WEAV $16.50
- IMCR $65.18
- AVG Volume (30 Days)
- WEAV 1.2M
- IMCR 146.2K
- Earning Date
- WEAV 02-20-2025
- IMCR 02-26-2025
- Dividend Yield
- WEAV N/A
- IMCR N/A
- EPS Growth
- WEAV N/A
- IMCR N/A
- EPS
- WEAV N/A
- IMCR N/A
- Revenue
- WEAV $204,314,000.00
- IMCR $296,312,000.00
- Revenue This Year
- WEAV N/A
- IMCR $28.89
- Revenue Next Year
- WEAV N/A
- IMCR $13.00
- P/E Ratio
- WEAV N/A
- IMCR N/A
- Revenue Growth
- WEAV 19.85
- IMCR 25.09
- 52 Week Low
- WEAV $8.10
- IMCR $27.69
- 52 Week High
- WEAV $17.63
- IMCR $72.56
- Technical
- Relative Strength Index (RSI)
- WEAV 25.41
- IMCR 47.96
- Support Level
- WEAV $16.63
- IMCR $28.41
- Resistance Level
- WEAV $17.63
- IMCR $30.49
- Average True Range (ATR)
- WEAV 0.59
- IMCR 1.47
- MACD
- WEAV -0.23
- IMCR -0.07
- Stochastic Oscillator
- WEAV 13.78
- IMCR 41.03
About WEAV Weave Communications Inc.
Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, it enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue primarily from subscription services.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.